All articles by
Lupin buys diabetes brands Ondero and Ondero Met from Boehringer Ingelheim
Lupin has been actively marketing Ondero and Ondero Met in the Indian market since 2015 through a co-marketing agreement with Boehringer Ingelheim India
GSK Announces AREXVY, Its Respiratory Syncytial Virus Vaccine, Is Now Available at All Major US Retail Pharmacies
Ahead of the fall and winter RSV season, AREXVY is now widely available in major retail pharmacies and anticipated to be covered by most Medicare and commercial insurance plans
NIH establishes Maternal Health Research Centers of Excellence
Initiative to support research to reduce pregnancy-related complications and deaths and promote maternal health equity.
Innovent gets NMPA nod of SINTBILO for hypercholesterolemia and mixed dyslipidemia
In three Phase 3 registrational clinical trials, there were clinically meaningful and statistically significant decreases from baseline in TC, non-HDL-C, ApoB, and Lp(a) levels
Seagen’s Tukysa combo met primary endpoint in Phase 3 breast cancer trial
The late-stage trial evaluated patients with unresectable locally advanced or metastatic HER2-positive breast cancer and had previously received therapy with a taxane and trastuzumab
Cipla launches CiplaMed 2.0 – knowledge sharing platform for healthcare practitioners (HCPs)
This initiative underscores the growing importance of digital platforms in the medical education and the use of technology to empower HCPs with vital information to cater to their patients
Sandoz’s biosimilar aflibercept met primary endpoint in Mylight Phase 3 study
The trial showed therapeutic equivalence in mean change of best corrected visual acuity (BCVA) from baseline to week eight between aflibercept and the reference biologic, Eylea
MediciNova gets new patent for scleroderma and systemic sclerosis therapy
MN-001 is an orally administered, small molecule compound with many mechanisms of action to treat chronic inflammatory and fibrotic diseases using its anti-inflammatory and anti-fibrosis effects
Novartis completes acquisition of Chinook Therapeutics
Acquisition of Chinook Therapeutics, a clinical-stage biopharmaceutical company, completed for $3.2bn upfront
Janssen’s Talvey secures FDA approval for multiple myeloma treatment
The FDA approval was based on results from the talquetamab Phase 2 MonumenTAL-1 study in which Talvey showed meaningful overall response rates of more than 70% with durable responses